Literature DB >> 10363664

Higher serum prolyl endopeptidase activity in patients with post-traumatic stress disorder.

M Maes1, A H Lin, S Bonaccorso, F Goossens, A Van Gastel, R Pioli, L Delmeire, S Scharpé.   

Abstract

BACKGROUND: It is reported that psychiatric disorders, such as depression and schizophrenia, are associated with changes in serum activity of prolyl endopeptidase (EC 3.4.21.26), a cytosolic endopeptidase, which cleaves peptide bonds on the carboxylside of proline in proteins of relatively small molecular mass. AIMS AND METHODS: The aims of the present study were to examine serum PEP activity in patients with post-traumatic stress disorder (PTSD) versus healthy volunteers. PEP activity has been determined by a fluorimetric assay.
RESULTS: Serum PEP activity was significantly higher in patients with PTSD than in normal volunteers. Serum PEP activity was significantly higher in patients with PTSD and concurrent major depression than in patients with PTSD without major depression. In PTSD patients, there were no significant correlations between serum PEP activity and severity of PTSD symptoms.
CONCLUSIONS: The results show that PTSD and, in particular, PTSD with concurrent major depression is associated with increased activity of PEP. RELEVANCE: these results may be of importance for the (i) neuroendocrine pathophysiology of PTSD since PEP degrades neuropeptides, such as arginine vasopressin (AVP) and thyrotropin releasing hormone (TRH); and (ii) etiology of PTSD, since PEP degrades behaviorally active neuropeptides, such as AVP, TRH, oxytocin, neurotensin and substance P, which play a key role in positive reinforcement, social interactions, emotions and stress responsivity.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10363664     DOI: 10.1016/s0165-0327(98)00086-x

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  10 in total

1.  ENPDA: an evolutionary structure-based de novo peptide design algorithm.

Authors:  Ignasi Belda; Sergio Madurga; Xavier Llorà; Marc Martinell; Teresa Tarragó; Mireia G Piqueras; Ernesto Nicolás; Ernest Giralt
Journal:  J Comput Aided Mol Des       Date:  2005-11-03       Impact factor: 3.686

2.  In search of an adult attachment stress provocation to measure effect on the oxytocin system: a pilot validation study.

Authors:  Michelle L Munro; Stephanie L Brown; Hossein Pournajafi-Nazarloo; C Sue Carter; William D Lopez; Julia S Seng
Journal:  J Am Psychiatr Nurses Assoc       Date:  2013-06-19       Impact factor: 2.385

3.  Exploring dissociation and oxytocin as pathways between trauma exposure and trauma-related hyperemesis gravidarum: a test-of-concept pilot.

Authors:  Julia Seng; Janis Miller; Mickey Sperlich; Cosmas J M van de Ven; Stephanie Brown; C Sue Carter; Israel Liberzon
Journal:  J Trauma Dissociation       Date:  2013

4.  Enhancement of fibrinolysis by inhibiting enzymatic cleavage of precursor α2-antiplasmin.

Authors:  K N Lee; K W Jackson; V J Christiansen; E K Dolence; P A McKee
Journal:  J Thromb Haemost       Date:  2011-05       Impact factor: 5.824

5.  Prolyl oligopeptidase is inhibited in relapsing-remitting multiple sclerosis.

Authors:  Jofre Tenorio-Laranga; Francisco Coret-Ferrer; Buenaventura Casanova-Estruch; María Burgal; J Arturo García-Horsman
Journal:  J Neuroinflammation       Date:  2010-04-06       Impact factor: 8.322

6.  Induced-fit mechanism for prolyl endopeptidase.

Authors:  Min Li; Changqing Chen; David R Davies; Thang K Chiu
Journal:  J Biol Chem       Date:  2010-05-05       Impact factor: 5.157

7.  Evolutionary computation and multimodal search: a good combination to tackle molecular diversity in the field of peptide design.

Authors:  Ignasi Belda; Sergio Madurga; Teresa Tarragó; Xavier Llorà; Ernest Giralt
Journal:  Mol Divers       Date:  2006-12-13       Impact factor: 3.364

8.  Alterations of prolyl endopeptidase activity in the plasma of children with autistic spectrum disorders.

Authors:  Naghi Momeni; Berit M Nordström; Vibeke Horstmann; Hassan Avarseji; Bengt V Sivberg
Journal:  BMC Psychiatry       Date:  2005-06-02       Impact factor: 3.630

9.  Elucidation of Molecular Mechanism(s) of Cognition Enhancing Activity of Bacomind®: A Standardized Extract of Bacopa Monnieri.

Authors:  Shekhar Dethe; M Deepak; Amit Agarwal
Journal:  Pharmacogn Mag       Date:  2016-07       Impact factor: 1.085

10.  Decreased Plasma Oxytocin Levels in Patients With PTSD.

Authors:  Claudia Carmassi; Donatella Marazziti; Federico Mucci; Alessandra Della Vecchia; Filippo Maria Barberi; Stefano Baroni; Gino Giannaccini; Lionella Palego; Gabriele Massimetti; Liliana Dell'Osso
Journal:  Front Psychol       Date:  2021-07-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.